The opioid receptor antagonist naloxonazine uncovers the pronounced ventilatory stimulant effects of fentanyl in freely-moving rats
- PMID: 40639478
- DOI: 10.1016/j.ejphar.2025.177925
The opioid receptor antagonist naloxonazine uncovers the pronounced ventilatory stimulant effects of fentanyl in freely-moving rats
Abstract
We previously reported that administration of an opioid receptor antagonist elicits pronounced increases in minute ventilation in rats where the respiratory effects of previously administered fentanyl had resolved. Thus, fentanyl induces the activation of an opioid receptor-dependent inhibitory system and a non-opioid receptor-dependent excitatory system - two systems with on-going counter-balancing effects on breathing. The objective of the present study was to determine whether administration of the potent, centrally-acting opioid receptor antagonist, naloxonazine (NLZ), during fentanyl-induced suppression of respiration, elicits an overshoot of breathing - above baseline values - suggesting the presence of an on-going excitatory ventilatory control system. The intravenous administration of 25, 50 or 75 μg/kg doses of fentanyl to separate groups of male Sprague Dawley rats elicited pronounced dose-dependent reductions in frequency of breathing, tidal volume, and minute ventilation. NLZ (1.5 mg/kg, IV) given 5 minutes after the injection of 25, 50 or 75 μg/kg doses of fentanyl - the timepoint in which the ventilatory depressant effects of fentanyl were most pronounced - elicited overshoots in frequency of breathing, tidal volume, and minute ventilation, as well as many other parameters including, peak inspiratory and expiratory flows and inspiratory and expiratory drives. This overshoot in breathing, which lasted for 20-30 min, was associated with minor increases in the non-eupneic breathing index (NEBI), suggesting that the responses were not accompanied by unwanted effects on respiratory timing and mechanics. Understanding the mechanism(s) by which this non-opioid receptor-dependent excitatory ventilatory system acts may lead to the development of novel ventilatory stimulants.
Keywords: fentanyl; male Sprague Dawley rats; naloxonazine; opioid receptors; ventilatory depression.
Copyright © 2025. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Reversal of morphine-induced respiratory depression with the µ1-opioid receptor antagonist naloxonazine engenders excitation and instability of breathing.Am J Physiol Lung Cell Mol Physiol. 2025 Jul 1;329(1):L97-L111. doi: 10.1152/ajplung.00045.2025. Epub 2025 May 14. Am J Physiol Lung Cell Mol Physiol. 2025. PMID: 40366705 Free PMC article.
-
Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing.Front Pharmacol. 2024 Apr 18;15:1381073. doi: 10.3389/fphar.2024.1381073. eCollection 2024. Front Pharmacol. 2024. PMID: 38698814 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Non-invasive ventilation for cystic fibrosis.Cochrane Database Syst Rev. 2017 Feb 20;2(2):CD002769. doi: 10.1002/14651858.CD002769.pub5. Cochrane Database Syst Rev. 2017. PMID: 28218802 Free PMC article.
-
Divergent ventilatory responses during opioid-induced respiratory depression in response to repeated fentanyl use.Am J Physiol Lung Cell Mol Physiol. 2025 Jul 1;329(1):L161-L171. doi: 10.1152/ajplung.00302.2024. Epub 2025 Jun 2. Am J Physiol Lung Cell Mol Physiol. 2025. PMID: 40455004 Free PMC article.
LinkOut - more resources
Full Text Sources